China and five Central Asian nations last week concluded their Second China-Central Asia Summit, unveiling a series of trade and investment agreements and underscoring Beijing's deepening economic commitment with the neighboring region.

Last week, the European Commission took a formal step towards imposing restrictions on government procurement of Chinese medical devices, based on an investigation of what it found to be restrictions on procurement practices in the Chinese market.

This past week, CTM covered the following issues: * China-U.S. talks in London * China-Africa ministerial meeting and China's zero tariff offer for African countries * China's antitrust review on Synopsys-Ansys merger * New Chinese guideline on customs procedure for export control of dual-use items * Taipei sanctions Chinese tech

Earlier this week, China's General Administration of Customs (GACC) published some guidelines outlining the procedures and required documentation for exporting controlled dual-use items.

Controversial from the start, a Chinese company's lease of the Port of Darwin became an issue during Australia's national elections in early May, and could be subject to a forced divestment.

China's Ministry of Commerce (MOFCOM) has outlined a detailed roadmap for extending zero-tariff treatment to imports from 53 African nations, solidifying a commitment made at last week's ministerial meeting. This initiative, part of a broader China-Africa Economic Partnership for Shared Development, will involve negotiations on "

Beijing has cast a new shadow over a $35 billion merger between U.S. software giants Synopsys and Ansys, postponing its regulatory approval. The decision comes as the latest ripple in escalating U.S.-China tech tensions.